Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q9)Dec 31, 2024 | (Q6)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q9)Dec 31, 2023 | (Q6)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 10.72%496.88M | 6.99%972.32M | ---- | -5.99%448.78M | ---- | 3.07%908.78M | ---- | 9.43%477.38M | ---- | -17.44%881.73M |
| Special items of operating revenue | -31.47%133.68M | 18.36%387.55M | ---- | 22.78%195.06M | ---- | 3.14%327.44M | ---- | 77.12%158.87M | ---- | 74.67%317.48M |
| Operating income | -2.06%630.56M | 10.00%1.36B | 1.19%643.84M | 3.09%1.24B | 20.97%636.24M | -4.05%1.2B | ||||
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Employee expense | -2.44%-75.09M | -15.37%-160.85M | ---- | -15.64%-73.3M | ---- | -16.06%-139.42M | ---- | 16.85%-63.39M | ---- | 25.21%-120.12M |
| Depreciation and amortization | 9.93%-27.5M | 11.03%-59.09M | ---- | 12.36%-30.53M | ---- | 10.84%-66.42M | ---- | 7.19%-34.83M | ---- | 3.94%-74.49M |
| Impairment and provision | -181.87%-3.2M | 37.58%-794K | ---- | -10.40%-1.14M | ---- | -69.15%-1.27M | ---- | 10.44%-1.03M | ---- | 89.88%-752K |
| -Other impairment is provision | -181.87%-3.2M | 37.58%-794K | ---- | -10.40%-1.14M | ---- | -69.15%-1.27M | ---- | 10.44%-1.03M | ---- | 89.88%-752K |
| Special items of operating profit | -8.19%-98.07M | -51.06%-248.06M | ---- | -7.94%-90.65M | ---- | 16.84%-164.22M | ---- | 18.78%-83.98M | ---- | 11.64%-197.46M |
| Operating profit | -4.80%426.7M | 3.03%891.08M | -1.06%448.23M | 7.26%864.9M | 47.27%453.01M | 3.29%806.4M | ||||
| Financing cost | 44.22%-58.34M | 17.80%-213.6M | ---- | 14.40%-104.59M | ---- | -127.54%-259.86M | ---- | -168.94%-122.18M | ---- | 8.28%-114.2M |
| Earning before tax | 7.20%368.37M | 11.97%677.48M | 3.87%343.64M | -12.59%605.05M | 26.18%330.83M | 5.48%692.2M | ||||
| Tax | -31.10%-41.45M | -29.52%-59.84M | ---- | -16.21%-31.62M | ---- | 35.47%-46.21M | ---- | 12.53%-27.21M | ---- | 24.40%-71.6M |
| After-tax profit from continuing operations | 4.77%326.92M | 10.52%617.63M | 2.77%312.02M | -9.95%558.84M | 31.39%303.63M | 10.52%620.6M | ||||
| Earning after tax | 4.77%326.92M | 10.52%617.63M | 7.69%476M | 2.77%312.02M | 8.09%147M | -9.95%558.84M | 7.28%442M | 31.39%303.63M | 12.40%136M | 10.52%620.6M |
| Profit attributable to shareholders | 4.77%326.92M | 10.52%617.63M | 2.77%312.02M | -9.95%558.84M | 31.39%303.63M | 10.52%620.6M | ||||
| Basic earnings per share | 4.79%0.1926 | 10.51%0.3639 | 2.74%0.1838 | -9.93%0.3293 | 31.45%0.1789 | 10.52%0.3656 | ||||
| Diluted earnings per share | 4.79%0.1926 | 10.51%0.3639 | 2.74%0.1838 | -9.93%0.3293 | 31.45%0.1789 | 10.52%0.3656 | ||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.